Application YC di Promakhos Therapeutics

Summer 2021Active

Promakhos Therapeutics ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareTherapeutics
Dimensione team: 2
Stato: Active
Lanciata: 2021

Founder

Katerina ChatziFounder
Jasper Edgar NeggersFounder

Cosa fa Promakhos Therapeutics

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Application YC di Promakhos Therapeutics, ricostruita

Domanda per Y Combinator

Promakhos Therapeutics, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Promakhos Therapeutics

Describe what your company does in 50 characters or less.

A therapeutics platform for curing inflammatory disorders

What is your company going to make? Please describe your product and what it does or will do.

We are building a platform that uses bacterial molecules to trigger the body's innate ability to regulate inflammation and heal itself. Our first target is Crohn's Disease, with plans to expand to type 1 Diabetes and Multiple Sclerosis. The product is a new kind of therapy designed to control inflammation from within.

Where do you live now, and where would the company be based after YC?

We live in Boston, MA and the company will remain based here after YC.

Explain your decision regarding location.

Boston is a hub for biotech and therapeutics research with access to top expertise and infrastructure, which is essential for us given the scientific complexity of our platform.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Promakhos Therapeutics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Promakhos Therapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Promakhos Therapeutics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Promakhos Therapeutics?

Promakhos Therapeutics apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato Promakhos Therapeutics?

Promakhos Therapeutics è stato fondato da Katerina Chatzi, Jasper Edgar Neggers.

Cosa fa Promakhos Therapeutics?

A therapeutics platform for curing inflammatory disorders

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Promakhos Therapeutics, e di ogni altro batch YC, è in YC Insights.